Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Advanced Accelerator hits brakes on IPO plans

    Advanced Accelerator Applications S.A. (Saint Genis Pouilly, France) said it will postpone its IPO on NASDAQ, citing adverse market conditions that prevented an "appropriate valuation." The company said in January that …

    Published on 2/6/2015
  • FINANCIAL NEWS: Poxel raises EUR 26.8M in IPO, private placement

    Poxel S.A. (Euronext:POXEL) gained EUR 0.53 to EUR 7.19 on Friday -- its first trading day after raising EUR 26.8 million ($30.4 million) in an IPO and concurrent private placement. Poxel raised EUR 3.6 million ($4.1 …

    Published on 2/6/2015
  • FINANCIAL NEWS: Woodford planning L200M fund

    Woodford Investment Management LLP plans to raise L200 million ($300.9 million) to launch Woodford Patient Capital Trust plc, a fund expected to be listed on the LSE. The fund will invest in 50-100 companies, primarily …

    Published on 2/6/2015
  • FINANCIAL NEWS: Armetheon raises $24.3M in series B

    Armetheon Inc. (Menlo Park, Calif.) raised $24.3 million in a series B round led by existing investor Hercules Bioventure Partners and new investor Capital TEN II. New investors China Development Industrial Bank …

    Published on 2/5/2015
  • FINANCIAL NEWS: Funding roundup: Intercept, Ultragenyx, Bind

    Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Bind Therapeutics Inc. (NASDAQ:BIND) raised a combined $359.5 million in follow-ons since market close on Wednesday.…

    Published on 2/5/2015
  • FINANCIAL NEWS: G1 Therapeutics raises $33M in B round

    G1 Therapeutics Inc. (Research Triangle Park, N.C.) raised $33 million in a series B round led by new investors Eshelman Ventures and RA Capital Management. New investors Lumira Capital and Tavistock Life Sciences' …

    Published on 2/5/2015
  • FINANCIAL NEWS: GHIT preps Grand Challenges, invests in antimalarials

    The Global Health Innovative Technology (GHIT) Fund launched its Grand Challenges initiative, which will award grants totaling about Y200 million ($1.7 million) annually in early stage development of drugs, diagnostics …

    Published on 2/5/2015
  • FINANCIAL NEWS: Bone Therapeutics raises EUR 32.2M in IPO

    Regenerative medicine play Bone Therapeutics S.A. (Euronext:BOTHE) raised EUR 32.2 million ($36.5 million) through the sale of 2 million shares at EUR 16 in an IPO, giving it a market cap of EUR 104.8 million ($118.7 …

    Published on 2/4/2015
  • FINANCIAL NEWS: Third Rock starts a Revolution

    Revolution Medicines Inc. (Redwood City, Calif.) raised $45 million in a series A round from lone investor Third Rock Ventures. The start-up uses a synthetic platform to discover and develop drugs based on natural …

    Published on 2/4/2015
  • FINANCIAL NEWS: Valneva raises EUR 45M

    Valneva SE (Euronext:VLA; VSE:VLA) raised EUR 45 million ($51 million) through the sale of 18.2 million shares at EUR 2.47 in a rights offering underwritten by Credit Agricole and Kempen & Co.The company is acquiring …

    Published on 2/4/2015
  • FINANCIAL NEWS: Guardant Health raises $50M series C round

    Diagnostics company Guardant Health Inc. (Redwood City, Calif.) raised $50 million in a series C round led by new investor Lightspeed Venture Partners. New investor Formation 8 and existing investors Khosla Ventures and…

    Published on 2/3/2015
  • FINANCIAL NEWS: Insiders back Lysosomal in $20M A round

    Lysosomal Therapeutics Inc. (Cambridge, Mass.) raised $20 million in a series A round from existing investors including Atlas Venture; Hatteras Venture Partners; Lilly Ventures; Sanofi-Genzyme BioVentures; Roche Venture…

    Published on 2/3/2015
  • FINANCIAL NEWS: Mann Bioinvest preparing new crossover fund

    Investment firm Mann Bioinvest has started fundraising for a London-listed, closed-end crossover fund. The firm hopes to raise L50-L100 million ($75.2-$150.5 million) for the new Mann Bio Pathfinder Fund, which will …

    Published on 2/3/2015
  • FINANCIAL NEWS: Ziopharm raises $87.5M in follow-on

    Ziopharm Oncology Inc. (NASDAQ:ZIOP) raised $87.5 million through the sale of 10 million shares at $8.75 in a follow-on underwritten by JPMorgan; BMO Capital Markets; Griffin Securities; Maxim Group; and Mizuho …

    Published on 2/3/2015
  • FINANCIAL NEWS: OrbiMed closes $924M royalty and credit fund

    OrbiMed Advisors closed its second healthcare royalty and credit fund with $924 million. OrbiMed Royalty Opportunities II includes $900 million from institutional investors and $24 million from the fund's general …

    Published on 2/2/2015
  • FINANCIAL NEWS: WaVe closes $18M series A round

    WaVe Life Sciences Pte. Ltd. (Singapore) raised $18 million in a series A round led by RA Capital Management and Kagoshima Shinsangyo Sosei Investment. Founding investor SNBL also participated. The company is developing…

    Published on 2/2/2015
  • FINANCIAL NEWS: Tracon takes haircut, raises $36M in IPO

    Oncology company Tracon Pharmaceuticals Inc. (NASDAQ:TCON) lost $0.60 to $9.40 in its first day of trading on Friday after raising $36 million in an IPO on NASDAQ through the sale of 3.6 million shares at $10. The price…

    Published on 1/30/2015
  • FINANCIAL NEWS: Venture tracks

    Canadian venture firm CTI Life Sciences hired Janelle Anderson as managing partner and promoted Shermaine Tilley to managing partner from partner. Anderson was a managing director at MRL Venture Fund, the corporate …

    Published on 1/30/2015
  • FINANCIAL NEWS: Atlas Genetics raises $20M in series C round

    Diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $20 million in a series C round from new investor RMI Partners, a subsidiary of Rusnano, and existing investors Novartis Venture Funds; Consort Medical …

    Published on 1/29/2015
  • FINANCIAL NEWS: Funding roundup: Omeros, Neovasc, Mirati, Xenoport

    Biotechs continued to raise money as a strong month of fundraising nears its end. Since market close on Wednesday, Omeros Corp. (NASDAQ:OMER), Neovasc Inc. (TSX:NVC; NASDAQ:NVCN), Mirati Therapeutics Inc. (NASDAQ:MRTX) …

    Published on 1/29/2015
  • FINANCIAL NEWS: Ascendis raises $108M in upsized IPO

    Ascendis Pharma A/S (NASDAQ:ASND) gained $0.83 to $18.83 in its first day of trading after raising $108 million in an upsized IPO on NASDAQ through the sale of 6 million American Depositary Shares (ADSs) at $18. The IPO…

    Published on 1/28/2015
  • FINANCIAL NEWS: Flex bumps up IPO, raises $86.4M

    Flex Pharma Inc. (NASDAQ:FLKS) raised $86.4 million in an upsized IPO on NASDAQ through the sale of 5.4 million shares at $16. The IPO price values Flex at $284.9 million. Last week, the neurology company proposed to …

    Published on 1/28/2015
  • FINANCIAL NEWS: Kolltan withdraws IPO

    Cancer play Kolltan Pharmaceuticals Inc. (New Haven, Conn.) withdrew its proposed IPO on NASDAQ. The company did not provide a reason in its SEC filing and did not respond to inquiries. In September, Kolltan filed to …

    Published on 1/28/2015
  • FINANCIAL NEWS: Spark upsizes proposed IPO

    Spark Therapeutics Inc. (Philadelphia, Pa.) amended its IPO on NASDAQ and now plans to sell 6.5 million shares at $19-$21. At $20, Spark would raise $130 million and be valued at $459.8 million. Last week, the gene …

    Published on 1/28/2015
  • FINANCIAL NEWS: Zosano raises $49.5 million in IPO

    Zosano Pharma Corp. (NASDAQ:ZSAN) gained a penny to $11.01 in its first day of trading after it raised $49.5 million in an IPO on NASDAQ through the sale of 4.5 million shares at $11. The price valued Zosano at $130 …

    Published on 1/27/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993